添加链接
link管理
链接快照平台
  • 输入网页链接,自动生成快照
  • 标签化管理网页链接
  • Factsheets , Key Irish Data
  • Regional Data , Key Irish Data
  • Prevalence Data , Key Irish Data
  • Treatment Data , Key Irish Data
  • Deaths Data , Key Irish Data
  • National Reports , Key Irish Data
  • Policy and Law , Key Irish Data
  • Newsletters , Key Irish Data
  • Alcohol Policy , Key Irish Data
  • Alcohol Research , Key Irish Data
  • Library Collection , Research Evidence,
  • Recovery , Research Evidence,
  • European Drugs Data , Research Evidence,
  • Best Practice Portal , Research Evidence,
  • Research Glossary , Research Evidence,
  • Doing Research? , Research Evidence,
  • Useful Websites , Research Evidence,
  • Drugs-library Subjects/Keywords , Research Evidence,
  • Browse by Provider , Course Directory,
  • Browse by Region , Course Directory,
  • Browse by Category , Course Directory,
  • Search dropdown menu, nav item
  • Simple Search , Search,
  • Advanced Search , Search,

  • 112kB

    External website: https://www.globaldrugsurvey.com/


    Data from 32,022 people from 22 countries were used in the preparation of this report.

    Global Drug Survey (GDS), established in 2012, is an independent research organisation based in London. We run the world’s largest drug survey. We use an encrypted online platform to collect anonymous drug use data from across the world. Our mission is to promote honest conversations about drug use and help people use drugs more safely regardless of the legal status of the drug. To date over 900,000 people have taken part in GDS research, and we have published over 65 academic papers. With the launch of GDS2022 in November 2021, we hope to reach 1 million participants by the end of 2021. GDS2021 was presented in 11 languages: Danish, Dutch, English, Finnish, French, German, Hungarian, Italian, Portuguese, and Romanian.

    GDS is not a prevalence study. GDS data are from a non-probability sample and thus our findings are not representative of the wider population. The rates of drug use in this sample are significantly higher when compared to the general population. The data can be used to describe use patterns and identify new drug trends. The majority of our participants tend to be young, experienced with the use of illicit drugs, and employed or in education. We have included questions that are relevant to marginalized and vulnerable groups of people who use drugs, yet these groups are largely underrepresented online.

    P.10 Some country differences were observed in the adoption of COVID-safe cannabis practices. Over two thirds of our respondents from Brazil reported increases in one or more COVID-safe cannabis use practices, and around 60% reported safety improvements in Canada, Germany, Ireland, Italy, Mexico, Spain, UK, and US. An unusually high proportion of the Romanian sample reported increased risk when using cannabis (40%).

    Exec summary P.3 On average respondents to GDS2021 reported regretting getting drunk on 21% of occasions (compared to 30% in GDS2020). Regret was highest among respondents from countries reporting getting drunk least often. The highest rates of regret were reported in Ireland (28.4%) and lowest in Denmark and Finland (17%).

    Item Type
    Report
    Publication Type
    Irish-related, International, Report
    Drug Type
    All substances
    Intervention Type
    Screening / Assessment
    Date
    December 2021
    Pages
    27 p.
    Publisher
    Global Drug Survey
    Place of Publication
    London
    EndNote

    Repository Staff Only: item control page